By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



150 Orchard Road
Orchard Plaza 08-02
  Singapore  238841   Singapore
Phone: n/a Fax: n/a



Company News
VolitionRX Partners With Two Market Access Consulting Agencies To Support Market Access Of NuQ Colorectal Cancer Tests In Europe 6/23/2015 7:17:11 AM
VolitionRX To Present At Two Upcoming Investor Conferences 5/19/2015 11:16:01 AM
VolitionRX CEO Cameron Reynolds To Present Informational Webinar 5/18/2015 11:02:02 AM
VolitionRX Announces First Quarter 2015 Financial Results And Business Update 5/12/2015 10:05:04 AM
VolitionRX Accelerates Clinical Trial With University Hospital Bonn, Germany Evaluating NuQ Assays In Most Prevalent Cancers 5/8/2015 6:26:39 AM
VolitionRX Schedules First Quarter 2015 Earnings Conference Call And Business Update For Tuesday, May 12, 2015 At 8:30 A.M. ET 5/6/2015 11:02:02 AM
VolitionRX Initiates Study With Hvidovre Hospital, Denmark, Specifically To Target NuQ Biomarker Panel For Colorectal Polyps 4/21/2015 12:15:34 PM
VolitionRX Adds Three New Laboratory Automation Systems To Expedite Sample Analysis For Its Large Ongoing Clinical Trials 4/9/2015 6:57:55 AM
VolitionRX Initiates Second Prostate Cancer Pilot Study Assessing Nucleosomics(R) Technology 3/5/2015 7:10:15 AM
VolitionRX Acquires Direct Ownership Of Nucleosomics Technology Patent 2/24/2015 6:32:51 AM